These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22848515)

  • 21. In vivo selection of OmpK35-deficient mutant after cefuroxime therapy for primary liver abscess caused by Klebsiella pneumoniae.
    Lee CH; Chia JH; Chu C; Wu TL; Liu JW; Su LH
    J Antimicrob Chemother; 2006 Oct; 58(4):857-60. PubMed ID: 16880175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
    Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
    J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of outer membrane protein K36 to antimicrobial resistance and virulence in Klebsiella pneumoniae.
    Chen JH; Siu LK; Fung CP; Lin JC; Yeh KM; Chen TL; Tsai YK; Chang FY
    J Antimicrob Chemother; 2010 May; 65(5):986-90. PubMed ID: 20211860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphoproteomics of Klebsiella pneumoniae NTUH-K2044 reveals a tight link between tyrosine phosphorylation and virulence.
    Lin MH; Hsu TL; Lin SY; Pan YJ; Jan JT; Wang JT; Khoo KH; Wu SH
    Mol Cell Proteomics; 2009 Dec; 8(12):2613-23. PubMed ID: 19696081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the Oxidative Stress Regulon Identifies
    Anes J; Dever K; Eshwar A; Nguyen S; Cao Y; Sivasankaran SK; Sakalauskaitė S; Lehner A; Devineau S; Daugelavičius R; Stephan R; Fanning S; Srikumar S
    mBio; 2021 Jun; 12(3):e0086721. PubMed ID: 34098732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae.
    Shen Z; Ding B; Ye M; Wang P; Bi Y; Wu S; Xu X; Guo Q; Wang M
    J Antimicrob Chemother; 2017 Jul; 72(7):1930-1936. PubMed ID: 28333323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae.
    Shields RK; Clancy CJ; Hao B; Chen L; Press EG; Iovine NM; Kreiswirth BN; Nguyen MH
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5793-7. PubMed ID: 26169413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional regulation of galF by RcsAB affects capsular polysaccharide formation in Klebsiella pneumoniae NTUH-K2044.
    Peng D; Li X; Liu P; Zhou X; Luo M; Su K; Chen S; Zhang Z; He Q; Qiu J; Li Y
    Microbiol Res; 2018 Nov; 216():70-78. PubMed ID: 30269858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CadC regulates cad and tdc operons in response to gastrointestinal stresses and enhances intestinal colonization of Klebsiella pneumoniae.
    Hsieh PF; Lin HH; Lin TL; Wang JT
    J Infect Dis; 2010 Jul; 202(1):52-64. PubMed ID: 20497056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Klebicin E, a pore-forming bacteriocin of Klebsiella pneumoniae, exploits the porin OmpC and the Ton system for translocation.
    Zhao X; Wang W; Zeng X; Xu R; Yuan B; Yu W; Wang M; Jia R; Chen S; Zhu D; Liu M; Yang Q; Wu Y; Zhang S; Huang J; Ou X; Sun D; Cheng A
    J Biol Chem; 2024 Mar; 300(3):105694. PubMed ID: 38301890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Klebsiella pneumoniae YfgL (BamB) lipoprotein contributes to outer membrane protein biogenesis, type-1 fimbriae expression, anti-phagocytosis, and in vivo virulence.
    Hsieh PF; Hsu CR; Chen CT; Lin TL; Wang JT
    Virulence; 2016 Jul; 7(5):587-601. PubMed ID: 27029012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation of
    Dulyayangkul P; Wan Nur Ismah WAK; Douglas EJA; Avison MB
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host adaptation and convergent evolution increases antibiotic resistance without loss of virulence in a major human pathogen.
    Fajardo-Lubián A; Ben Zakour NL; Agyekum A; Qi Q; Iredell JR
    PLoS Pathog; 2019 Mar; 15(3):e1007218. PubMed ID: 30875398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of IS1R and IS10R elements inserted into ompk36 porin gene of two multidrug-resistant Klebsiella pneumoniae hospital strains.
    Lev AI; Astashkin EI; Shaikhutdinova RZ; Platonov ME; Kartsev NN; Volozhantsev NV; Ershova ON; Svetoch EA; Fursova NK
    FEMS Microbiol Lett; 2017 May; 364(10):. PubMed ID: 28402509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA adenine methylation modulates pathogenicity of Klebsiella pneumoniae genotype K1.
    Fang CT; Yi WC; Shun CT; Tsai SF
    J Microbiol Immunol Infect; 2017 Aug; 50(4):471-477. PubMed ID: 26427879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited.
    Hsu CR; Lin TL; Chen YC; Chou HC; Wang JT
    Microbiology (Reading); 2011 Dec; 157(Pt 12):3446-3457. PubMed ID: 21964731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing the role of porin mutations in susceptibility of beta lactamase producing Klebsiella pneumoniae isolates to ceftaroline and ceftaroline-avibactam.
    Khalid A; Lubián AF; Ma L; Lin RCY; Iredell JR
    Int J Infect Dis; 2020 Apr; 93():252-257. PubMed ID: 32061861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
    Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D
    Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli.
    George AM; Hall RM; Stokes HW
    Microbiology (Reading); 1995 Aug; 141 ( Pt 8)():1909-1920. PubMed ID: 7551053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.
    Bialek-Davenet S; Mayer N; Vergalli J; Duprilot M; Brisse S; Pagès JM; Nicolas-Chanoine MH
    Sci Rep; 2017 Jul; 7(1):6722. PubMed ID: 28751669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.